Potential Dilution from the Exercise of Stock Acquisition Rights
First written in FY2018. 14 of 18 entries say "Materialised", first in FY2019-Q3. Latest entry: FY2024.
Amazia moved to the "Worse" side of this theme in 2019, 2 years before the typical company in this theme (2021).
The whole theme swung hardest in 2017: 28 of 54 companies on the "Worse" side.
52 other companies' latest entry also says "Mitigated".
- FY2024MitigatedAnnual report
「As of the end of the fiscal year, the number of potential shares represented by these stock acquisition rights was 267,200, equivalent to 4.0% of the 6,757,800 issued shares.」
The number of potential shares and their ratio to total issued shares declined from 283,600 shares and 4.2% at the end of the previous fiscal year to 267,200 shares and 4.0%. Meanwhile, 3,200 shares were issued during the fiscal year through the exercise of the fifth series of stock acquisition rights. - FY2024-Q1MaterialisedAnnual report
「1 October 2023–31 December 2023 (Note) 3,200 6,757,800 720 366,724 720 363,010 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the first quarter accounting period, 3,200 shares were added to the total number of issued shares through the exercise of stock acquisition rights, while capital and capital reserves each increased by ¥720 thousand. - FY2023MitigatedAnnual report
「As of the end of the fiscal year, the number of potential shares represented by these stock acquisition rights was 283,600, equivalent to 4.2% of the 6,754,600 issued shares.」
The number of potential shares and their ratio to total issued shares declined from 363,600 shares and 5.4% at the end of the previous fiscal year to 283,600 shares and 4.2%. - FY2023-Q3MitigatedAnnual report
「Expiration of the sixth series of stock acquisition rights (Expiration date: 11 May 2023; number of shares: 80,000)」
The expiration of rights representing 80,000 shares among the sixth series of stock acquisition rights is disclosed, reducing one source of potential dilution. - FY2022MaterialisedAnnual report
「1 October 2021–30 September 2022 20,000 6,754,600 4,500 366,004 4,500 362,290 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the fiscal year, 20,000 shares were issued through the exercise of stock acquisition rights, bringing the total number of issued shares to 6,754,600. The number of potential shares at the fiscal year-end was updated to 363,600, equivalent to 5.4% of the total number of issued shares. - FY2022-Q3MaterialisedAnnual report
「1 April 2022–30 June 2022 (Note) 6,000 6,745,000 1,350 363,844 1,350 360,130 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the third quarter accounting period, 6,000 shares were added to the total number of issued shares through the exercise of stock acquisition rights, while capital and capital reserves each increased by ¥1.350 million. - FY2022-Q2MaterialisedAnnual report
「1 January 2022–31 March 2022 (Note) 2,000 6,739,000 450 362,494 450 358,780 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the second quarter accounting period, 2,000 shares were added to the total number of issued shares through the exercise of stock acquisition rights, while capital and capital reserves each increased by ¥450 thousand. - FY2022-Q1MaterialisedAnnual report
「1 October 2021–31 December 2021 (Note) 2,400 6,737,000 540 362,044 540 358,330 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the first quarter accounting period, 2,400 shares were added to the total number of issued shares through the exercise of stock acquisition rights, while capital and capital reserves each increased by ¥540 thousand. - FY2021MaterialisedAnnual report
「As of the end of the fiscal year, the number of potential shares represented by these stock acquisition rights was 385,600, equivalent to 5.7% of the 6,734,600 issued shares.」
The company updated the number of potential shares represented by stock acquisition rights and the potential dilution, while 24,400 stock acquisition rights were actually exercised during the fiscal year. - FY2021-Q3MaterialisedAnnual report
「1 April 2021–30 June 2021 (Note) 2,000 6,734,600 375 361,504 375 357,790 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the third quarter accounting period, 2,000 shares were added to the total number of issued shares through the exercise of stock acquisition rights, while capital and capital reserves each increased by ¥375 thousand. - FY2021-Q2MaterialisedAnnual report
「1 January 2021–31 March 2021 (Note) 6,800 6,732,600 1,530 361,129 1,530 357,415 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the second quarter accounting period, 6,800 shares were added to the total number of issued shares through the exercise of stock acquisition rights, while capital and capital reserves each increased by ¥1.530 million. - FY2021-Q1MaterialisedAnnual report
「1 October 2020–31 December 2020 (Note) 15,600 6,725,800 3,510 359,599 3,510 355,885 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the first quarter accounting period, 15,600 shares were added to the total number of issued shares through the exercise of stock acquisition rights, while capital and capital reserves each increased by ¥3.510 million. - FY2020-Q3MaterialisedAnnual report
「1 April 2020–30 June 2020 (Note 2) 10,800 6,704,600 2,430 355,039 2,430 351,325」
During the third quarter accounting period, 10,800 shares were added to the total number of issued shares through the exercise of stock acquisition rights, while capital and capital reserves each increased by ¥2.430 million. - FY2020-Q2MaterialisedAnnual report
「1 January 2020–31 March 2020 (Note 1) 18,200 3,346,900 7,605 352,609 7,605 348,895 (Note) 1. Increase resulting from the exercise of stock acquisition rights.」
During the second quarter accounting period, 18,200 shares were added to the total number of issued shares through the exercise of stock acquisition rights, while capital and capital reserves each increased by ¥7.605 million. - FY2020-Q1MaterialisedAnnual report
「1 October 2019–31 December 2019 (Note) 14,600 3,328,700 6,480 345,004 6,480 341,290 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the first quarter accounting period, 14,600 shares were added to the total number of issued shares through the exercise of stock acquisition rights, while capital and capital reserves each increased by ¥6.480 million. - FY2019MaterialisedAnnual report
「Between 1 October 2019 and 30 November 2019, the total number of issued shares increased by 9,400 through the exercise of stock acquisition rights, while capital and capital reserves each increased by ¥4.230 million.」
An additional 9,400 shares were issued through the exercise of stock acquisition rights by the filing date, resulting in actual dilution. - FY2019-Q3MaterialisedAnnual report
「1 April 2019–30 June 2019 8,800 3,311,100 3,300 337,399 3,300 333,685 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the third quarter accounting period, 8,800 shares were added to the total number of issued shares through the exercise of stock acquisition rights, and the conversion of potential shares into actual shares occurred. - FY2018First statedAnnual report
「As of the end of the month preceding the date of filing this document, 30 November 2018, the number of potential shares represented by these stock acquisition rights was 206,200, equivalent to 6.3% of the 3,258,000 issued shares.」
The Company discloses the possibility that the exercise of stock acquisition rights could dilute the value of existing shareholders' shares and their voting rights.